Thermo Fisher Scientific Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 42,857 million compared to USD 44,915 million a year ago. Net income was USD 5,995 million compared to USD 6,950 million a year ago.

Basic earnings per share from continuing operations was USD 15.52 compared to USD 17.75 a year ago. Diluted earnings per share from continuing operations was USD 15.45 compared to USD 17.63 a year ago.